DE60131100D1 - Verfahren zur behandlung bestimmter augenkrankheiten - Google Patents

Verfahren zur behandlung bestimmter augenkrankheiten

Info

Publication number
DE60131100D1
DE60131100D1 DE60131100A DE60131100A DE60131100D1 DE 60131100 D1 DE60131100 D1 DE 60131100D1 DE 60131100 A DE60131100 A DE 60131100A DE 60131100 A DE60131100 A DE 60131100A DE 60131100 D1 DE60131100 D1 DE 60131100D1
Authority
DE
Germany
Prior art keywords
eye
treatment
eye diseases
human patient
visual acuity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60131100A
Other languages
English (en)
Other versions
DE60131100T4 (de
DE60131100T2 (de
Inventor
Gerard M Nolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60131100D1 publication Critical patent/DE60131100D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60131100A 2001-01-31 2001-08-03 Verfahren zur behandlung bestimmter augenkrankheiten Expired - Fee Related DE60131100D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/773,878 US6605640B2 (en) 2001-01-31 2001-01-31 Method of treating certain eye diseases
PCT/US2001/024259 WO2002060451A1 (en) 2001-01-31 2001-08-03 Method of treating certain eye diseases

Publications (1)

Publication Number Publication Date
DE60131100D1 true DE60131100D1 (de) 2007-12-06

Family

ID=25099599

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60131100A Expired - Fee Related DE60131100D1 (de) 2001-01-31 2001-08-03 Verfahren zur behandlung bestimmter augenkrankheiten
DE60131100T Expired - Lifetime DE60131100T4 (de) 2001-01-31 2001-08-03 Verfahren zur behandlung bestimmter augenkrankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60131100T Expired - Lifetime DE60131100T4 (de) 2001-01-31 2001-08-03 Verfahren zur behandlung bestimmter augenkrankheiten

Country Status (7)

Country Link
US (1) US6605640B2 (de)
EP (1) EP1365771B9 (de)
JP (1) JP2004530645A (de)
AT (1) ATE376425T1 (de)
CA (1) CA2436397A1 (de)
DE (2) DE60131100D1 (de)
WO (1) WO2002060451A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2527175A1 (en) * 2003-04-18 2004-10-28 Advanced Medicine Research Institute Remedies for diseases to be applied to eye
CA2522043A1 (en) * 2003-04-25 2004-11-11 Gerard M. Nolan Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage
JP2005154320A (ja) * 2003-11-25 2005-06-16 Ss Pharmaceut Co Ltd 眼疾患治療薬
CA3031370A1 (en) 2016-08-19 2018-02-22 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
BR112021002168A2 (pt) * 2018-08-08 2021-05-04 Seinda Pharmaceutical Guangzhou Corporation composições e métodos para o tratamento de presbiopia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288735A (en) 1989-05-02 1994-02-22 Trager Seymour F Treatment of glaucoma
WO1999044603A1 (en) 1998-03-06 1999-09-10 Sponsel William E Composition and method for treating macular disorders
US6273092B1 (en) 2000-09-22 2001-08-14 Gerard M. Nolan Methods for treating various eye disorders

Also Published As

Publication number Publication date
ATE376425T1 (de) 2007-11-15
EP1365771A4 (de) 2005-12-21
EP1365771B1 (de) 2007-10-24
DE60131100T4 (de) 2009-07-09
WO2002060451A1 (en) 2002-08-08
DE60131100T2 (de) 2008-07-31
EP1365771A1 (de) 2003-12-03
EP1365771B9 (de) 2008-11-12
US6605640B2 (en) 2003-08-12
US20020103167A1 (en) 2002-08-01
CA2436397A1 (en) 2002-08-08
JP2004530645A (ja) 2004-10-07

Similar Documents

Publication Publication Date Title
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
DE60239612D1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
NO20055937L (no) Anvendels av triglyseridoljer inneholdende gamma-linolensyrerester og linolsyrerester for behandlingen av nevrodegenerativ sydkom
ATE330631T1 (de) Antikörperfragmente zur lokalen behandlung von augenerkrankungen
MX2009005279A (es) Derivados de n-(metil)-1h-pirazol-3-amina, n-(metil)-piridin-2-ami na y n-(metil)-tiazol-2-amina para el tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide, tal como por ejemplo alzheimer.
SE9803710D0 (sv) Use of certain drugs for treating nerve root injury
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
WO2005063297A3 (en) Melatonin combination therapy for improving sleep quality
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
EA200401070A1 (ru) Способы лечения сосудистых заболеваний
ATE331527T1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
DE602004002394D1 (de) (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN
ATE435026T1 (de) Verfahren zur prävention und behandlung von diabetes mit neurturin
ATE375141T1 (de) Verfahren und mittel zur behandlung und vorbeugung von erkrankungen der hinteren augenkammer
DE69534620D1 (de) Verfahren zur behandlung von augenerkrankungen
DE60131100D1 (de) Verfahren zur behandlung bestimmter augenkrankheiten
ATE410172T1 (de) Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
DE602005027228D1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
HUP0402061A2 (hu) Rosszindulatú daganatok kezelésére alkalmas, egy biszfoszfonát, egy COX-2 inhibitor és egy taxol kombinációját tartalmazó gyógyszerkészítmények
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
DE602004027655D1 (de) Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set
MXPA05013975A (es) Tratamiento de enfermedades asociadas con amiloide y epileptogenesis.
WO2003045322A3 (en) Method for treating and preventing pancreatitis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee